Genocea Biosciences (GNCA) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends Genocea Biosciences (NASDAQ:GNCA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.61%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)7Amount OfInsider Selling(Last 3 Years)$791,721.35 Get GNCA Insider Trade Alerts Want to know when executives and insiders are buying or selling Genocea Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GNCA Insider Buying and Selling by Quarter Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Genocea Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/1/2022Jacquelyn L SumerInsiderSell2,500$0.06$150.00 5/31/2022William D ClarkCEOSell117,244$0.06$7,034.64 5/26/2022Diantha DuvallCFOSell24,407$0.08$1,952.56 5/25/2022Ali BehbahaniDirectorSell4,445,093$0.08$355,607.44 5/25/2022Jessica Baker FlechtnerInsiderSell16,525$0.09$1,487.25 5/24/2022Paul Edward WalkerMajor ShareholderSell5,931,843$0.07$415,229.01 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/4/2022Diantha DuvallCFOSell963$1.25$1,203.75 4/4/2022Jessica Baker FlechtnerInsiderSell1,212$1.25$1,515.00 4/4/2022William D ClarkCEOSell3,924$1.25$4,905.00 3/16/2022Girish N AakaluInsiderSell2,397$1.10$2,636.70 (Data available from 1/1/2013 forward) GNCA Insider Trading Activity - Frequently Asked Questions Who is on Genocea Biosciences's Insider Roster? The list of insiders at Genocea Biosciences includes Ali Behbahani, Diantha Duvall, Girish N Aakalu, Jacquelyn L Sumer, Jessica Baker Flechtner, Paul Edward Walker, and William D Clark. Learn more on insiders at GNCA. What percentage of Genocea Biosciences stock is owned by insiders? 1.61% of Genocea Biosciences stock is owned by insiders. Learn more on GNCA's insider holdings. Genocea Biosciences Key ExecutivesMr. William D. Clark M.B.A. (Age 53)Pres, CEO & Director Compensation: $837.42kDr. Jessica Baker Flechtner Ph.D. (Age 50)Chief Scientific Officer Compensation: $585.18kMs. Diantha Duvall CPA (Age 50)M.B.A., CFO & Sec. More Insider Trading Tools from MarketBeat Related Companies CMRA Insider Trading EVLO Insider Trading AMPE Insider Trading EFTR Insider Trading BTMDW Insider Trading FBIOP Insider Trading AGEN Insider Trading IOVA Insider Trading MRNA Insider Trading BNTX Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Big Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside This page (NASDAQ:GNCA) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genocea Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genocea Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
